Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice

Blood

Volumn 117, Issue 20, 2011, Pages 5413-5424

  Hansell, Chris A H ^a   Schiering, Chris ^a,b   Kinstrie, Ross ^a   Ford, Laura ^a   Bordon, Yvonne ^a   McInnes, Iain B ^a   Goodyear, Carl S ^a   Nibbs, Robert J B ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD11B ANTIGEN; CD5 ANTIGEN; CELL MARKER; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR5; CHEMOKINE RECEPTOR D6; D6 PROTEIN; IMMUNOGLOBULIN M; INTERLEUKIN 10; PHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CALCIUM TRANSPORT; CELL COMPARTMENTALIZATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLOGY; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; INNATE IMMUNITY; INTERNALIZATION; LEUKOCYTE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 79956265751     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-11-317115     Document Type: Article

References (50)

1. Allman D, Pillai S. Peripheral B cell subsets. Curr Opin Immunol. 2008;20(2):149-157.
2. Fagarasan S, Kawamoto S, Kanagawa O, Suzuki K. Adaptive immune regulation in the gut: T cell-dependent and T cell-independent IgA synthesis. Annu Rev Immunol. 2010;28:243-273.
3. Haas KM, Poe JC, Steeber DA, Tedder TF. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity. 2005;23(1):7-18. (Pubitemid 41019653)
4. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med. 2000;192(2):271-280. (Pubitemid 30470309)
5. Alugupalli KR, Gerstein RM, Chen J, Szomolanyi- Tsuda E, Woodland RT, Leong JM. The resolution of relapsing fever borreliosis requires IgM and is concurrent with expansion of B1b lymphocytes. J Immunol. 2003;170(7):3819-3827. (Pubitemid 36359252)
6. Binder CJ, Horkko S, Dewan A, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med. 2003;9(6):736-743. (Pubitemid 36749223)
7. Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol. 2008;9(1):54-62. (Pubitemid 350286204)
8. Attanavanich K, Kearney JF. Marginal zone, but not follicular B cells, are potent activators of naive CD4 T cells. J Immunol. 2004;172(2):803-811. (Pubitemid 38113736)
9. Bouaziz JD, Yanaba K, Tedder TF. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev. 2008;224(1):201-214.
10. Hastings WD, Gurdak SM, Tumang JR, Rothstein TL. CD5+/Mac-1- peritoneal B cells: a novel B cell subset that exhibits characteristics of B-1 cells. Immunol Lett. 2006;105(1):90-96. (Pubitemid 43674133)
11. Ghosn EE, Yang Y, Tung J, Herzenberg LA, Herzenberg LA. CD11b expression distinguishes sequential stages of peritoneal B-1 development. Proc Natl Acad Sci U S A. 2008;105(13):5195-5200. (Pubitemid 351738533)
12. Ansel KM, Harris RB, Cyster JG. CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity. Immunity. 2002;16(1):67-76. (Pubitemid 34143217)
13. Wells SM, Kantor AB, Stall AM. CD43 (S7) expression identifies peripheral B cell subsets. J Immunol. 1994;153(12):5503-5515. (Pubitemid 24377686)
14. Won WJ, Kearney JF. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol. 2002;168(11):5605-5611. (Pubitemid 34556141)
15. Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol. 2004;22:891-928. (Pubitemid 38680444)
16. Fagarasan S, Shinkura R, Kamata T, et al. Alymphoplasia (aly)-type nuclear factor kappaB-inducing kinase (NIK) causes defects in secondary lymphoid tissue chemokine receptor signaling and homing of peritoneal cells to the gut-associated lymphatic tissue system. J Exp Med. 2000;191(9):1477-1486. (Pubitemid 30257345)
17. Lu TT, Cyster JG. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 2002;297(5580):409-412. (Pubitemid 34790772)
18. Ha SA, Tsuji M, Suzuki K, et al. Regulation of B1 cell migration by signals through Toll-like receptors. J Exp Med. 2006;203(11):2541-2550. (Pubitemid 44664623)
19. Kunisawa J, Kurashima Y, Gohda M, et al. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production. Blood. 2007;109(9):3749-3756. (Pubitemid 46641725)
20. Cinamon G, Matloubian M, Lesneski MJ, et al. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol. 2004;5(7):713-720. (Pubitemid 39023303)
21. Berberich S, Forster R, Pabst O. The peritoneal micromilieu commits B cells to home to body cavities and the small intestine. Blood. 2007;109(11):4627-4634. (Pubitemid 46827751)
22. Höpken UE, Achtman AH, Kruger K, Lipp M. Distinct and overlapping roles of CXCR5 and CCR7 in B-1 cell homing and early immunity against bacterial pathogens. J Leukoc Biol. 2004;76(3):709-718. (Pubitemid 39129105)
23. Hopken UE, Winter S, Achtman AH, Kruger K, Lipp M. CCR7 regulates lymphocyte egress and recirculation through body cavities. J Leukoc Biol. 2010;87(4):671-682.
24. Foussat A, Balabanian K, Amara A, et al. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol. 2001;31(2):350-359. (Pubitemid 32166588)
25. McKimmie CS, Fraser AR, Hansell C, et al. Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J Immunol. 2008;181(11):8171-8181.
26. Kin NW, Crawford DM, Liu J, Behrens TW, Kearney JF. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J Immunol. 2008;180(10):6663-6674.
27. Mantovani A, Bonecchi R, Locati M. Tuning inflammation and immunity by chemokine sequestration: decoys and more. Nat Rev Immunol. 2006;6(12):907-918. (Pubitemid 44851733)
28. Graham GJ. D6 and the atypical chemokine receptor family: novel regulators of immune and inflammatory processes. Eur J Immunol. 2009;39(2):342-351.
29. Fra AM, Locati M, Otero K, et al. Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J Immunol. 2003;170(5):2279-2282. (Pubitemid 36245612)
30. Weber M, Blair E, Simpson CV, et al. The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol Biol Cell. 2004;15(5):2492-2508. (Pubitemid 38580663)
31. Vetrano S, Borroni EM, Sarukhan A, et al. The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6. Gut. 2010;59(2):197-206.
32. Bordon Y, Hansell CA, Sester DP, Clarke M, Mowat AM, Nibbs RJ. The atypical chemokine receptor D6 contributes to the development of experimental colitis. J Immunol. 2009;182(8):5032-5040.
33. Galliera E, Jala VR, Trent JO, et al. beta- Arrestin-dependent constitutive internalization of the human chemokine decoy receptor D6. J Biol Chem. 2004;279(24):25590-25597. (Pubitemid 38756820)
34. McCulloch CV, Morrow V, Milasta S, et al. Multiple roles for the C-terminal tail of the chemokine scavenger D6. J Biol Chem. 2008;283(12):7972- 7982.
35. Madigan J, Freeman DJ, Menzies F, et al. Chemokine scavenger D6 is expressed by trophoblasts and aids the survival of mouse embryos transferred into allogeneic recipients. J Immunol. 2010;184(6):3202-3212.
36. Nibbs RJ, Kriehuber E, Ponath PD, et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am J Pathol. 2001;158(3):867-877. (Pubitemid 32221780)
37. Martinez de la Torre Y, Buracchi C, Borroni EM, et al. Protection against inflammation- and auto-antibody- caused fetal loss by the chemokine decoy receptor D6. Proc Natl Acad Sci U S A. 2007;104(7):2319-2324. (Pubitemid 46391395)
38. Jamieson T, Cook DN, Nibbs RJ, et al. The chemokine receptor D6 limits the inflammatory response in vivo. Nat Immunol. 2005;6(4):403-411. (Pubitemid 41716781)
39. Yang Y, Tung JW, Ghosn EE, Herzenberg LA, Herzenberg LA. Division and differentiation of natural antibody-producing cells in mouse spleen. Proc Natl Acad Sci U S A. 2007;104(11):4542-4546. (Pubitemid 47186261)
40. Montecino-Rodriguez E, Leathers H, Dorshkind K. Identification of a B-1 B cell-specified progenitor. Nat Immunol. 2006;7(3):293-301.
41. Won WJ, Foote JB, Odom MR, Pan J, Kearney JF, Davis RS. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J Immunol. 2006;177(10):6815-6823. (Pubitemid 44715046)
42. Thiriot A, Drapier AM, Vieira P, et al. The Bw cells, a novel B cell population conserved in the whole genus Mus. J Immunol. 2007;179(10):6568-6578.
43. Hastings WD, Tumang JR, Behrens TW, Rothstein TL. Peritoneal B-2 cells comprise a distinct B-2 cell population with B-1b-like characteristics. Eur J Immunol. 2006;36(5):1114-1123.
44. Berberich S, Dahne S, Schippers A, et al. Differential molecular and anatomical basis for B cell migration into the peritoneal cavity and omental milky spots. J Immunol. 2008;180(4):2196-2203.
45. Shulga-Morskaya S, Dobles M, Walsh ME, et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol. 2004;173(4):2331-2341. (Pubitemid 39063089)
46. Gavin AL, Duong B, Skog P, et al. deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J Immunol. 2005;175(1):319-328. (Pubitemid 40884334)
47. Scholz JL, Crowley JE, Tomayko MM, et al. BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc Natl Acad Sci U S A. 2008;105(40):15517-15522.
48. Carvalho TL, Mota-Santos T, Cumano A, Demengeot J, Vieira P. Arrested B lymphopoiesis and persistence of activated B cells in adult interleukin 7(-/-) mice. J Exp Med. 2001;194(8):1141-1150. (Pubitemid 32995783)
49. Mack M, Cihak J, Simonis C, et al. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice. J Immunol. 2001;166(7):4697-4704. (Pubitemid 32233757)
50. Islam SA, Chang DS, Colvin RA, et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T(H)2 cells. Nat Immunol. 2011;12(2):167-177.